- Nordic Nanovector - Notice of Annual General Meeting on 28 June 2023
- Nordic Nanovector announces agreement to acquire Thor Medical, an emerging producer of alpha-emitters for radiopharmaceuticals to treat cancer
- Nordic Nanovector Publishes Data from the PARADIGME Phase 2 Clinical Trials with Betalutin® on European Clinical Trials Database
- NORDIC NANOVECTOR - ANNUAL GENERAL MEETING POSTPONED
- NORDIC NANOVECTOR - ANNUAL AND REMUNERATION REPORTS APPROVED
Nordic Nanovector ASA (8NN:DEU) closed at 0.132, 277.14% above the 52 week low of 0.035 set on May 19, 2023.
0.035May 19 20230.781Jun 10 2022
Short selling activityProvided by S&P Global Market Intelligence
|Market cap||111.28m NOK|
|EPS (TTM)||-2.70 |
Data delayed at least 15 minutes, as of Jun 07 2023 18:05 BST.